← Eichor
Condition: Leflunomide Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Leflunomide

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis
Phase N/A · 2 location(s) · Foundation University Islamabad · NCT07388407Leflunomide for Henoch-Schonlein Purpura
NA · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05937880Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
Phase 2 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06229340Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06540937Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children
Phase 1/Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05937191Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
Phase 1/Phase 2 · 1 location(s) · West Virginia University · NCT06923488Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
Phase 2 · 3 location(s) · Tata Memorial Centre · NCT07709013Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05789030Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalaz
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT02714634Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Phase 1 · 1 location(s) · Deborah Doroshow · NCT04997993Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Tran
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05443425Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase 2 · 8 location(s) · City of Hope Medical Center · NCT04508790Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06454383
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.